Shenzhen New Industries Biomedical Engineering Co., Ltd.
SZSE:300832.SZ
60.24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 1,653.653 | 1,327.918 | 973.696 | 939.147 | 772.609 | 693.997 | 538.207 | 451.695 | 249.119 | 252.872 | 141.268 | 75.116 |
| Depreciation & Amortization
| 154.33 | 116.482 | 97.003 | 79.145 | 52.961 | 39.572 | 35.582 | 8.698 | 23.038 | 5.652 | 4.389 | 3.531 |
| Deferred Income Tax
| 0 | 3.155 | 18.319 | -14.476 | -2.219 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | -80.706 | 93.881 | 141.401 | 0 | 0 | 0 | 0 | 105.9 | 0 | 0 | 0 |
| Change In Working Capital
| -413.665 | -304.839 | -354.036 | -178.418 | 20.839 | -16.71 | -38.031 | -46.378 | -73.182 | -13.092 | -12.199 | -25.082 |
| Accounts Receivables
| -277.176 | -240.162 | -154.655 | -60.45 | -34.141 | -22.822 | -28.321 | -37.771 | -51.694 | -38.359 | -32.591 | 0 |
| Inventory
| -136.49 | -229.949 | -227.729 | -222.514 | -42.361 | -51.325 | -21.476 | -8.607 | -23.746 | -13.757 | 5.572 | -26.529 |
| Accounts Payables
| 84.015 | 162.117 | 10.029 | 119.022 | 99.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -84.015 | 3.155 | 18.319 | -14.476 | -2.219 | 34.616 | -16.554 | 0 | -49.435 | 0.665 | -17.77 | 1.447 |
| Other Non Cash Items
| 103.826 | -99.618 | -55.645 | 9.855 | -14.682 | -14.893 | -11.029 | -460.392 | 106.952 | 8.038 | 4.873 | 2.239 |
| Operating Cash Flow
| 1,498.144 | 962.391 | 773.218 | 976.655 | 831.727 | 701.967 | 524.729 | 486.811 | 305.927 | 253.471 | 138.331 | 55.805 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -322.196 | -403.218 | -342.939 | -254.817 | -327.11 | -284.866 | -176.507 | -56.029 | -119.496 | -129.207 | -142.95 | -12.299 |
| Acquisitions Net
| 0.088 | 0.661 | 0.243 | 256.595 | 327.522 | -0 | 176.843 | 0.6 | 0.06 | 0.001 | 0 | 0 |
| Purchases Of Investments
| -7,509.5 | -10,196.26 | -9,617.823 | -11,769.581 | -9,595.62 | -6,630.777 | -4,980.735 | -2,647.04 | -2,323.307 | -1,105 | 0 | 0 |
| Sales Maturities Of Investments
| 7,535.882 | 10,010.099 | 9,035.953 | 9,528.175 | 9,636.853 | 6,665.192 | 5,000.576 | 2,654.907 | 2,328.523 | 1,107.223 | 1.414 | 0 |
| Other Investing Activites
| 5 | -5 | 0 | -254.817 | -327.11 | 0.878 | -176.507 | 10.24 | 5.6 | 6 | 8.258 | 5.74 |
| Investing Cash Flow
| -290.725 | -593.718 | -924.566 | -2,494.446 | -285.464 | -249.573 | -156.331 | -37.322 | -108.619 | -120.983 | -133.278 | -6.559 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -4.113 | 0 | -3.593 | 0 | 0 | 0 | 0 | 0 | 0 | -57.32 | 57.32 | 0 |
| Common Stock Issued
| 0 | 25.67 | 0 | 0 | -0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -16.286 | -21.616 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -550.003 | -471.676 | -412.35 | -618.984 | 0 | -101.167 | -185.2 | -55.56 | -42.4 | -22.594 | -11.907 | -9.715 |
| Other Financing Activities
| -14.489 | -25.77 | 129.561 | 1,272.655 | -8.309 | -1.2 | -1.972 | -2.877 | 100 | 0 | -0 | 28.8 |
| Financing Cash Flow
| -568.605 | -497.445 | -287.433 | 653.671 | -8.309 | -102.367 | -187.172 | -58.437 | 57.6 | -79.914 | 45.413 | 19.085 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 8.694 | -9.132 | -14 | -33.486 | -2.927 | -0.367 | 1.9 | 1.343 | 0.755 | -0.575 | -0.403 | 0.153 |
| Net Change In Cash
| 564.839 | -137.904 | -452.78 | -897.606 | 535.026 | 349.66 | 183.126 | 392.395 | 255.663 | 41.293 | 48.65 | 68.483 |
| Cash At End Of Period
| 1,048.265 | 478.121 | 616.024 | 1,068.805 | 1,966.41 | 1,431.385 | 1,081.725 | 898.6 | 506.204 | 250.541 | 209.248 | 160.598 |